Two narratives are running in parallel at Renk right now – and they could hardly be more contradictory. The Augsburg-based defence supplier is sitting on a record order book, its top executives have just received a vote of confidence for the long haul, and a major institutional investor is quietly building a bigger stake. Yet the shares keep sliding, hitting a fresh 52-week low as a sector-wide sell-off overpowers any good news specific to the company.
The stock closed at €43.99 on Wednesday, marking a 14.68% decline over just seven trading days and a 20.28% drop since the start of the year. At that level, Renk is trading roughly 50% below its 2025 high of €88.73, which was reached as recently as October. The distance to the 200-day moving average has ballooned to 26.58%, a technical signal that investors are pricing in a fundamentally changed outlook.
Against that backdrop, Renk’s supervisory board sent a strong signal of continuity by extending CEO Dr. Alexander Sagel’s contract by five years, locking him in until the end of March 2032. In a business defined by long project cycles in defence and industrial drivetrains, such a move is more than window dressing – it underpins the strategic direction Sagel is driving, including the “NextGen Mobility” initiative focused on autonomous and hybrid propulsion for military vehicles and Renk America’s role as a supplier for the US Army’s medium tracked vehicle programmes, including drive-by-wire systems for the AMPV.
At the same time, BlackRock has increased its exposure to the stock. The asset manager disclosed a total stake of 4.44% as of 7 May, up from roughly 3.63%. Direct voting rights account for 2.95%, while the remainder is held via financial instruments, mainly securities lending. While such moves by big passive players are not necessarily a directional bet, the timing is notable: the stake increase came just as the share price was plumbing new lows.
Should investors sell immediately? Or is it worth buying Renk?
Operationally, the business tells a sharply different story from the one on the trading screen. Renk’s total order backlog reached a record €6.9 billion at the end of the first quarter of 2026, with firm orders rising 14% from year-end 2025 to around €2.6 billion. More than 90% of the planned revenue for the full year is already under contract. After a 20% revenue jump in 2025 to €1.37 billion and order intake of €1.57 billion, management is guiding for sales above €1.5 billion in 2026 and adjusted EBIT of between €255 million and €285 million.
The disconnect is largely attributable to the broader defence sector, which has come under pressure since a disappointing earnings call from rival Rheinmetall soured sentiment. Renk has been dragged down by the same wave, even though its own order momentum shows no signs of flagging. Analysts at mwb research and Warburg Research argue the sell-off is overdone – mwb has a price target of €53, well above current levels.
With the annual general meeting set for 10 June – where a dividend of €0.58 per share is up for a vote – and a management roadshow scheduled for 20 May, investors will be looking for concrete evidence that the operational strength can eventually pull the stock out of its tailspin. For now, the market is demanding proof that Renk’s growth story can buck the sector trend.
Ad
Renk Stock: Buy or Sell?! New Renk Analysis from May 14 delivers the answer:
The latest Renk figures speak for themselves: Urgent action needed for Renk investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from May 14.
Renk: Buy or sell? Read more here...
